Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Adrienne Shnier"'
Publikováno v:
BMJ Open, Vol 12, Iss 3 (2022)
Objectives This study investigates the information and policies that Canadian patient groups post on their publicly available websites about their relationships with pharmaceutical companies.Design Cross-sectional study.Setting Canadian national pati
Externí odkaz:
https://doaj.org/article/db100cf9ce8640ac9453cc5ddfbb5ef7
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e68633 (2013)
INTRODUCTION: The education of medical students should be based on the best clinical information available, rather than on commercial interests. Previous research looking at university-wide conflict of interest (COI) policies used in Canadian medical
Externí odkaz:
https://doaj.org/article/54b0e024d7e44cbcbb4d32f4e815194c
Publikováno v:
Health Policy. 124:231-238
Background Because not all medicines are equally safe, effective, and affordable, health systems often use formularies to define explicitly which medicines will be included and excluded from coverage. Objective We sought to synthesize methods and fin
Autor:
Joel Lexchin, Ainsley Moore, Kimberly A. Turner, Lisa Cosgrove, Brett D. Thombs, Sharon E. Straus, Adrienne Shnier, Katharine Elder
Publikováno v:
CMAJ
Background The producers of clinical practice guidelines (CPGs) may not disclose industry funding in their CPGs. We reviewed Canadian national CPGs to examine the existence and disclosure of industry-related organizational funding in the CPGs, financ
Autor:
Joel Lexchin, Adrienne Shnier
Publikováno v:
International Journal of Risk & Safety in Medicine. 29:1-16
BACKGROUND Professional medical associations (PMAs) play a crucial role in providing accredited continuing medical education (CME) to physicians. Funding from the pharmaceutical industry may lead to biases in CME. OBJECTIVE This study examines public
Autor:
Adrienne Shnier
Publikováno v:
Accounting, Finance, Sustainability, Governance & Fraud: Theory and Application ISBN: 9789811514234
The legal concept of the “special relationship”, arising in the areas of negligence and intentional torts, has been afforded little attention in products liability cases in Canadian law. The special relationship has been applied in cases wherein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d07cb71d902060d6c380e91dd8fd0b44
https://doi.org/10.1007/978-981-15-1424-1_9
https://doi.org/10.1007/978-981-15-1424-1_9
Autor:
Jillian Clare Kohler, Adrienne Shnier, Paul Thacker, Marc-André Gagnon, Joel Lexchin, James Crombie
Publikováno v:
Indian Journal of Medical Ethics.
Corruption in healthcare generally and specifically in the pharmaceutical arena has recently been highlighted in reports by Transparency International. This article focuses on four areas of corruption: legislative/regulatory, financial, ideological/e
Publikováno v:
Health policy (Amsterdam, Netherlands). 122(5)
“Sunshine” policy, aimed at making financial ties between health professionals and industry publicly transparent, has recently gone global. Given that transparency is not the sole means of managing conflict of interest, and is unlikely to be effe
Publikováno v:
BMC Health Services Research
Background Clinical practice guidelines are widely distributed by medical associations and relied upon by physicians for the best available clinical evidence. International findings report that financial conflicts of interest (FCOI) with drug compani
Autor:
Adrienne Shnier, Harriet G Rosenberg
Publikováno v:
BMJ. :j3437
The editorial by Doshi and Godlee rightly argues for better communication among regulatory scientists, medical journals, and the public, especially when evidence held by regulators differs from journal publications.1 Watchdog groups, such as the heal